Martin Madaus

Martin Madaus

Vorsitzender bei REPLIGEN CORPORATION

Vermögen: 2 Mio $ am 31.05.2026

66 Jahre
Health Technology
Commercial Services
Health Services

Profil

Dr. Martin D.
Madaus
is an Independent Director at Azenta, Inc., a Chairman at Repligen Corp.
and an Executive Chairman at Emulate, Inc. He is on the Board of Directors at Azenta, Inc., Unchained Labs LLC, Candela Medical, Inc., Candela Corp., Massachusetts High Technology Council, Inc., Syntis Bio, Inc. and Ultivue, Inc. Dr. Madaus was previously employed as an Independent Director by Hologic, Inc., an Independent Director by Standard BioTools, Inc., a Chief Operations Officer by Sherlock Biosciences, Inc., a Chairman & Chief Executive Officer by Ortho-Clinical Diagnostics, Inc., an Independent Director by Covidien Ltd., an Independent Director by Mettler-Toledo International, Inc., a Chairman, President & Chief Executive Officer by Millipore Corp., a Chairman, President & Chief Executive Officer by Millipore SA/NV, a President & Chief Executive Officer by Roche Diagnostics Corp., a Chairman & Chief Executive Officer by Ortho-Clinical Diagnostics, and a Vice President-Business Development by Roche Molecular Systems, Inc. He also served on the board at Quanterix Corp., Analytical Life Science & Diagnostics Association, Massachusetts Technology Collaborative, New England Healthcare Institute, Pharmaceutical Product Development LLC, Predictive Biosciences, Inc. and Young Men's Christian Association of Greater Boston, Inc. He received his doctorate degree from Ludwig-Maximilians-Universität München and a doctorate degree from The University of Veterinary Medicine Hanover.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
14.05.2026 8’392 ( 0.01% ) 1 Mio $ 31.05.2026
02.01.2025 291’541 ( 0.63% ) 892 115 $ 31.05.2026
05.02.2026 7’405 ( 0.02% ) 169 426 $ 31.05.2026

Aktive Positionen von Martin Madaus

UnternehmenPositionBeginn
CANDELA MEDICAL, INC. Direktor/Vorstandsmitglied 01.05.2018
REPLIGEN CORPORATION Vorsitzender 13.03.2026
AZENTA, INC. Direktor/Vorstandsmitglied 30.01.2024
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 01.07.2021
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Vorsitzender 19.03.2020

Ehemalige bekannte Positionen von Martin Madaus

UnternehmenPositionEnde
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Martin Madaus im Detail an

Ausbildung von Martin Madaus

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

68

Beziehungen ersten Grades

29

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen29

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Technology Services

Health Technology

Commercial Services

Health Services

Commercial Services

Health Services

Commercial Services

Electronic Technology

Analytical Life Science & Diagnostics Association

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Martin Madaus
- 40 %: Die besten Tools - exklusiv für Abonnenten - um schon heute die Top-Anlagechancen von morgen zu erkennen!
T
:
:
PROFITIEREN SIE JETZT